PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.31%
Revenue growth under 50% of ADI's 10.56%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.64%
Gross profit growth under 50% of ADI's 14.94%. Michael Burry would be concerned about a severe competitive disadvantage.
12.92%
EBIT growth below 50% of ADI's 93.53%. Michael Burry would suspect deeper competitive or cost structure issues.
10.33%
Operating income growth under 50% of ADI's 93.53%. Michael Burry would be concerned about deeper cost or sales issues.
34.92%
Net income growth under 50% of ADI's 256.54%. Michael Burry would suspect the firm is falling well behind a key competitor.
33.33%
EPS growth under 50% of ADI's 267.22%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
33.33%
Diluted EPS growth under 50% of ADI's 266.67%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-29.56%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-27.87%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
41.96%
Dividend growth of 41.96% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-48.82%
Negative OCF growth while ADI is at 112.36%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-112.03%
Negative FCF growth while ADI is at 902.17%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
3.06%
10Y revenue/share CAGR under 50% of ADI's 141.71%. Michael Burry would suspect a lasting competitive disadvantage.
-24.01%
Negative 5Y CAGR while ADI stands at 69.55%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-27.73%
Negative 3Y CAGR while ADI stands at 77.70%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-52.04%
Negative 5Y OCF/share CAGR while ADI is at 180.15%. Joel Greenblatt would question the firm’s operational model or cost structure.
385.77%
3Y OCF/share CAGR above 1.5x ADI's 192.09%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
143.28%
10Y net income/share CAGR of 143.28% while ADI is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
73.69%
5Y net income/share CAGR at 50-75% of ADI's 99.68%. Martin Whitman might see a shortfall in operational efficiency or brand power.
48.33%
3Y net income/share CAGR above 1.5x ADI's 23.81%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
145.52%
5Y equity/share CAGR at 75-90% of ADI's 165.16%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
49.68%
Below 50% of ADI's 176.17%. Michael Burry suspects a serious short-term disadvantage in building book value.
83.48%
Dividend/share CAGR of 83.48% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
77.18%
Dividend/share CAGR of 77.18% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-2.22%
Negative near-term dividend growth while ADI invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
7.14%
AR growth well above ADI's 3.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.72%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-1.20%
Negative asset growth while ADI invests at 1.77%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
45.27%
BV/share growth above 1.5x ADI's 10.31%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-3.48%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
10.68%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-1.52%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.